CASTOR1 and neoplasm: While the constitutively phosphorylated mutant S14D has a reduced inhibitory effect, the dead phosphorylated mutant inhibits tumor growth even more effective than the WT CASTOR1 (Fig. 5d–g), possibly due to its dominant-negative effect.